TP53 and neoplasm: Then, quantification of tumor vessels and immune cell infiltration by CD31 and CD45 staining, respectively, revealed significantly higher contents in HMMRTg/Tg;Brca1f/f;Trp53+/- than in Brca1f/f;Trp53+/− tumors (Fig. 3h, i).